Obesity Advisor, by Haymarket & Obesity Medicine Association, is a dedicated online resource for healthcare professionals on the frontlines of obesity care.
Treatment with the #GLP1 RA #orforglipron significantly decreases the apnea-hypopnea index, lowers hypoxic burden, and improves cardiovascular risk factors in patients with moderate-to-severe OSA and #obesity.
https://t.co/BDXm1sine1
Weight gain isn’t just calories. Everyday chemicals called "#obesogens" (BPA, PFAS, phthalates) can disrupt hormones and trigger fat cell creation.
Easy swaps:
• Never heat food in plastic
• Ditch nonstick pans
• Go fragrance-free
Learn more: https://t.co/f5lAmTwAPm
#MedEd
October Clinical Roundup 🩺
As #ObesityMedicine evolves, staying ahead of new therapeutics and clinical workflows is key.
In our top spotlight, Dr. Masson (@MountSinaiNYC) breaks down prioritizing functional goals in older adults: https://t.co/6ULZdlt3cE
A rarely discussed side of #obesitycare: privacy & stigma.
When choosing oral #GLP1s vs weekly shots, discretion at home is often the real decider.
Clinicians: Does privacy drive your treatment choice?
🎥 https://t.co/m96MFpMifY
With @OMAsocial.
#MedTwitter
"Two kidneys, two tests." 🩺
Routine vitals miss early #CKM risk. Gregg Sherman, MD (@NACECME) & Dr. Jay Shubrook (@WeAreTouro) explain why eGFR + UACR catches both kidney and heart disease.
➡️ https://t.co/1DB52DqTye
#MedX#PrimaryCare
#GLP1 RAs and dual incretin therapies provide substantial therapeutic benefits for a variety of chronic conditions, including #CVD, heart failure, osteoarthritis, sleep apnea, and fatty liver disease.
https://t.co/M3NBGEtJkD
To optimize #cardiometabolic outcomes amid the rapid expansion of treatment options, family physicians must understand the role of #AI tools in patient engagement.
https://t.co/mZ0Uoe9NlL
Ambient #AI scribes reduces electronic #health record documentation time, allowing clinicians to focus on empathetic patient communication; however, clinicians should be aware of potential errors introduced by AI systems
https://t.co/njJevosF56
Why telling #fibromyalgia patients to "exercise" backfires—and why reframing it as "movement" builds adherence.
Dr. Gregg Sherman of @NACECME & Dr. Jill Schneiderhan of @umich share clinical pearls for #chronicpain care. With @OMAsocial.
Watch: https://t.co/7Df4imXvgc
Applying specific #diagnostic thresholds for common #cardiovascular concerns allows primary care clinicians to confidently manage low-risk conditions and expedite cardiology referrals for high-risk patients.
https://t.co/i4WUB1czWE
The physician-only social network #Roon uses #AI to facilitate cross-specialty clinical collaboration, enabling physicians to efficiently curate medical research and share practice-enhancing insights.
https://t.co/AxnRgGzjT0
The American Academy of Family Physicians (#AAFP) has established a new policy and resource hub designed to address the persistent gender #WageGap and promote compensation equity.
https://t.co/fQfHWmjhCH
“We don’t identify the person as their disease—they are living with it.”
#WeightBias impacts health outcomes and care access. Dr. Tracy Norfleet, of @OMAsocial shares how clinicians can eliminate stigma through person-first care.
🎥 https://t.co/KZmAZsFlkg
#ObesityMedicine
Proactive screening in high-risk patients prevents severe outcomes like cirrhosis and liver failure.
Dr. Pankaj Rajvanshi of @OMAsocial explains how targeted testing transforms care.
🎙️ Full #AIAdvisorAmplified episode: https://t.co/OL5KtFsEiO
#ObesityMedicine#MASLD